Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings

Sample article from our Pet Care

SAN DIEGO , August 24, 2023 (press release) –

Q2 2023 Operating Results

  • Comparable sales grew 3.2 percent year-over-year and 7.0 percent on a two-year basis, resulting in the 19th consecutive quarter of comparable sales growth
  • Net revenue of $1.53 billion increased 3.4 percent year-over-year
  • Net loss of $14.6 million, or $(0.05) per share compared to net income of  $13 .5 million, or  $0 .05 per share in the prior year
  • Adjusted Net Income1 decreased  $27 .2 million to $16.3 million
  • Adjusted EBITDA1 of $112.6 million compared to  $133 .5 million in the prior year
  • Adjusted Earnings Per Share1 of  $0.06 , compared to  $0 .16 per share in the prior year
  • Operating Cash Flow of  $96 .6 million compared to  $42 .6 million in the prior year
  • Free Cash Flow1 of $44.6 million , compared to $(27.7) million in the prior year

Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, today announced its second quarter 2023 financial results.

In the second quarter of 2023, Petco delivered net revenue of $1.53 billion , up 3.4 percent versus prior year, driven by strength in the company's consumables business, up 6.8 percent versus prior year, and services and other business, up 30.6 percent versus prior year.  Second quarter revenue growth was partially offset by the company's supplies and companion animal business, down 9.4 percent versus prior year.  Net loss was $14.6 million or $(0.05) per share, driven in part by a $0.04 per share increase in interest expense year-over-year, compared to net income of $13.5 million or $0.05 per share in the prior year.  Adjusted Net Income1 was $16.3 million or $0.06 per share, compared to $43.5 million or $0.16 per share in the prior year.  Adjusted EBITDA1 was $112.6 million compared to $133.5 million in the prior year.

"We continue to focus on execution through an uncertain environment, delivering our 19th consecutive quarter of comp sales growth, with ongoing strength in consumables and services, particularly in vet," said Petco CEO Ron Coughlin . "With discretionary spending continuing to be pressured, we're taking numerous strategic actions to strengthen our business, including initiatives to unlock a targeted $150 million in cost savings and productivity enhancements by the end of fiscal 2025. These actions, combined with the enduring competitive advantages of our differentiated offering, will position us even better to deliver sustainable and profitable growth for the long term."

"In Q2, we delivered solid top line results and strong free cash flow," said Petco CFO Brian LaRose . "That said, the shift in consumer spending and pressures on our discretionary business mean we're revising our guidance accordingly. Looking ahead, we remain focused on debt paydown and cash flow, both of which will be supported by our productivity initiatives in addition to tightly controlled expense management." 

In the second quarter of 2023, Petco paid down $25 million in principal on its term loan.  In August, the company further paid down an additional $15 million in principal on its term loan for a total of $75 million in principal payments year-to-date.  The company continues to target a total of $100 million in principal payments for fiscal 2023 and remains committed to strengthening its balance sheet through de-levering.

The company also initiated a cost action plan in the quarter and estimates annualized gross run rate cost savings of $150 million by the end of fiscal 2025, from merchandise, supply chain, and G&A categories.  In year one, the company expects to achieve $40 million in savings. In Q2 2023, the company recorded $6 million in headcount reduction-related charges related to the cost action plan.

(1)

Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share ("Adjusted EPS"), and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

Fiscal 2023 Guidance:

The company is updating its fiscal 2023 guidance for Adjusted EBITDA, Adjusted EPS and Capital Expenditures and now expects:

Metric*

2023 Guidance

Net Revenue

$6.150 billion to $6.275 billion

Adjusted EBITDA

$460 million to $480 million

Adjusted EPS

$0.24 to $0.30

Capital Expenditures

$215 million to $225 million

 

*Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. Adjusted EPS guidance assumes approximately $145 to $155 million of interest expense, an estimated $43 to $53 million increase in interest expense year-over-year, a 26 percent tax rate, and a 269 million weighted average diluted share count. The Company estimates that the increase in interest expense will impact Adjusted EPS by approximately $0.12 to $0.15 per share.  Furthermore, Fiscal 2023 will be a 53-week year, leading to an incremental week of operations.  Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission .

Earnings Conference Call Webcast Information:

Management will host an earnings conference call on August 24, 2023 at 8:00 AM Eastern Time to discuss the company's financial results.  The conference call will be accessible through a live webcast. Interested investors and other individuals can access the webcast, earnings release, earnings presentation, and infographic via the company's investor relations page at ir.petco.com. A replay of the webcast will be archived on the company's investor relations page through September 7, 2023 until approximately 5:00PM Eastern Time .

About Petco, The Health + Wellness Co. :

Founded in 1965, Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. We've consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 pet care centers across the U.S. , Mexico and Puerto Rico , which offer merchandise, companion animals, grooming, training and a growing network of on-site veterinary hospitals and mobile veterinary clinics. Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app. In tandem with Petco Love, a life-changing organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for nearly 7 million animals.

Forward-Looking Statements:

This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including statements regarding our fiscal year 2023 guidance. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation and prevailing interest rates; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflict in Ukraine ), health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; and (xx) the other risks, uncertainties and other factors identified under "Risk Factors" and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

 

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)

 
               
   

13 Weeks Ended

 
   

July 29 ,
2023

 

July 30 ,
2022

 

Percent
Change

 

Net sales

 

$     1,530,734

 

$     1,480,797

 

3 %

 

Cost of sales

 

937,730

 

886,320

 

6 %

 

Gross profit

 

593,004

 

594,477

 

(0 %)

 

Selling, general and administrative expenses

 

568,967

 

544,472

 

4 %

 

Operating income

 

24,037

 

50,005

 

(52 %)

 

Interest income

 

(764)

 

(137)

 

458 %

 

Interest expense

 

37,493

 

21,820

 

72 %

 

Loss on partial extinguishment of debt

 

305

 

 

N/M

 

Other non-operating (income) loss

 

(1,795)

 

10,259

 

N/M

 

(Loss) income before income taxes and income from
   equity method investees

 

(11,202)

 

18,063

 

N/M

 

Income tax expense

 

6,732

 

6,638

 

1 %

 

Income from equity method investees

 

(3,328)

 

(2,031)

 

64 %

 

Net (loss) income

 

(14,606)

 

13,456

 

N/M

 

Net loss attributable to noncontrolling interest

 

 

 

N/M

 

Net (loss) income attributable to Class A and B-1 common
   stockholders

 

$        (14,606)

 

$          13,456

 

N/M

 
               

Net (loss) income per Class A and B-1 common share:

             

Basic

 

$            (0.05)

 

$             0.05

 

N/M

 

Diluted

 

$            (0.05)

 

$             0.05

 

N/M

 
               

Weighted average shares used in computing net (loss) income per Class A
   and B-1 common share:

             

Basic

 

267,163

 

265,431

 

1 %

 

Diluted

 

267,163

 

265,835

 

0 %

 
               

 

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)

 
   
   

July 29 ,
2023

   

January 28 ,
2023

 

ASSETS

           

Current assets:

           

Cash and cash equivalents

 

$

173,014

   

$

201,901

 

Receivables, less allowance for credit losses1

   

66,258

     

49,580

 

Merchandise inventories, net

   

675,441

     

652,430

 

Prepaid expenses

   

54,880

     

51,274

 

Other current assets

   

55,247

     

60,809

 

Total current assets

   

1,024,840

     

1,015,994

 

Fixed assets

   

2,090,367

     

1,987,560

 

Less accumulated depreciation

   

(1,270,141)

     

(1,184,233)

 

Fixed assets, net

   

820,226

     

803,327

 

Operating lease right-of-use assets

   

1,401,834

     

1,397,761

 

Goodwill

   

2,196,664

     

2,193,941

 

Trade name

   

1,025,000

     

1,025,000

 

Other long-term assets

   

193,698

     

176,806

 

Total assets

 

$

6,662,262

   

$

6,612,829

 

LIABILITIES AND EQUITY

           

Current liabilities:

           

Accounts payable and book overdrafts

 

$

477,748

   

$

381,213

 

Accrued salaries and employee benefits

   

90,796

     

89,929

 

Accrued expenses and other liabilities

   

219,910

     

217,556

 

Current portion of operating lease liabilities

   

281,415

     

309,766

 

Current portion of long-term debt and other lease liabilities

   

5,077

     

22,794

 

Total current liabilities

   

1,074,946

     

1,021,258

 

Senior secured credit facilities, net, excluding current portion

   

1,588,523

     

1,628,331

 

Operating lease liabilities, excluding current portion

   

1,159,696

     

1,148,155

 

Deferred taxes, net

   

294,094

     

303,121

 

Other long-term liabilities

   

130,239

     

130,487

 

Total liabilities

   

4,247,498

     

4,231,352

 

Commitments and contingencies

           

Stockholders' equity:

           

Class A common stock2

   

230

     

228

 

Class B-1 common stock3

   

38

     

38

 

Class B-2 common stock4

   

     

 

Preferred stock5

   

     

 

Additional paid-in-capital

   

2,196,235

     

2,152,342

 

Retained earnings

   

216,470

     

232,967

 

Accumulated other comprehensive income (loss)

   

1,791

     

(4,098)

 

Total stockholders' equity

   

2,414,764

     

2,381,477

 

Total liabilities and stockholders' equity

 

$

6,662,262

   

$

6,612,829

 
   

(1)

Allowances for credit losses are $1,164 and $952 , respectively

(2)

Class A common stock, $0.001 par value: Authorized - 1.0 billion shares; Issued and outstanding - 229.8 million and 228.3 million shares, respectively

(3)

Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

(4)

Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

(5)

Preferred stock, $0.001 par value: Authorized - 25.0 million shares; Issued and outstanding - none

 

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited and subject to reclassification)

 
   
   

26 Weeks Ended

 
   

July 29 ,
2023

   

July 30 ,
2022

 

Cash flows from operating activities:

           

Net (loss) income

 

$

(16,498)

   

$

37,258

 

Adjustments to reconcile net (loss) income to net cash provided by
  operating activities:

           

Depreciation and amortization

   

97,919

     

95,570

 

Amortization of debt discounts and issuance costs

   

2,446

     

2,456

 

Provision for deferred taxes

   

(11,002)

     

9,216

 

Equity-based compensation

   

46,248

     

25,117

 

Impairments, write-offs and losses on sale of fixed and other assets

   

1,035

     

1,369

 

Loss on partial extinguishment of debt

   

746

     

 

Amounts reclassified out of accumulated other comprehensive income (loss)

   

1,055

     

 

Income from equity method investees

   

(6,458)

     

(5,194)

 

Non-cash operating lease costs

   

211,576

     

210,946

 

Other non-operating (income) loss

   

(4,614)

     

9,945

 

Changes in assets and liabilities:

           

Receivables

   

(16,679)

     

10,856

 

Merchandise inventories

   

(23,011)

     

(48,225)

 

Prepaid expenses and other assets

   

(14,237)

     

(21,932)

 

Accounts payable and book overdrafts

   

97,062

     

12,626

 

Accrued salaries and employee benefits

   

1,221

     

(37,345)

 

Accrued expenses and other liabilities

   

(1,238)

     

5,148

 

Operating lease liabilities

   

(232,518)

     

(205,884)

 

Other long-term liabilities

   

1,212

     

(1,839)

 

Net cash provided by operating activities

   

134,265

     

100,088

 

Cash flows from investing activities:

           

Cash paid for fixed assets

   

(114,023)

     

(136,190)

 

Cash paid for acquisitions, net of cash acquired

   

(2,040)

     

(2,888)

 

Cash paid for interest in veterinary joint venture

   

     

(35,000)

 

Proceeds from investment

   

10,248

     

 

Proceeds from sale of assets

   

     

2,127

 

Net cash used in investing activities

   

(105,815)

     

(171,951)

 

Cash flows from financing activities:

           

Borrowings under long-term debt agreements

   

     

4,000

 

Repayments of long-term debt

   

(60,000)

     

(12,500)

 

Payments for finance lease liabilities

   

(3,349)

     

(2,964)

 

Proceeds from employee stock purchase plan and stock option exercises

   

2,454

     

2,591

 

Tax withholdings on stock-based awards

   

(4,873)

     

(13,461)

 

Net cash used in financing activities

   

(65,768)

     

(22,334)

 
             

Net decrease in cash, cash equivalents and restricted cash

   

(37,318)

     

(94,197)

 

Cash, cash equivalents and restricted cash at beginning of period

   

213,727

     

221,890

 

Cash, cash equivalents and restricted cash at end of period

 

$

176,409

   

$

127,693

 

 

NON-GAAP FINANCIAL MEASURES

The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

The tables below reflect the calculation of Adjusted EBITDA (include Trailing Twelve Month Adjusted EBITDA), Adjusted Net Income, Adjusted EPS, and Free Cash Flow, for the thirteen weeks ended July 29, 2023 , compared to the thirteen weeks ended July 30, 2022 as well as the twelve-month period ended January 28, 2023 .

Adjusted EBITDA and Trailing Twelve Month Adjusted EBITDA

Adjusted EBITDA, including Trailing Twelve Month Adjusted EBITDA, is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended January 28, 2023 filed with the SEC on March 28, 2023 for additional information on Adjusted EBITDA.

           

(dollars in thousands)

 

13 Weeks Ended

 

Reconciliation of Net (Loss) Income Attributable to Class A and B-1
   Common Stockholders to Adjusted EBITDA

 

July 29 ,
2023

 

July 30 ,
2022

 

Net (loss) income attributable to Class A and B-1 common stockholders

 

$     (14,606)

 

$      13,456

 

Add (deduct):

         

Interest expense, net

 

36,729

 

21,683

 

Income tax expense

 

6,732

 

6,638

 

Depreciation and amortization

 

48,664

 

48,603

 

Income from equity method investees

 

(3,328)

 

(2,031)

 

Loss on partial extinguishment of debt

 

305

 

 

Asset impairments and write offs

 

1,031

 

1,207

 

Equity-based compensation

 

24,119

 

12,895

 

Other non-operating (income) loss

 

(1,795)

 

10,259

 

Mexico joint venture EBITDA (1)

 

8,544

 

6,501

 

Acquisition-related integration costs (2)

 

 

10,859

 

Other costs (3)

 

6,183

 

3,427

 

Adjusted EBITDA

 

$    112,578

 

$    133,497

 

Net sales

 

$ 1,530,734

 

$ 1,480,797

 

Net margin (4)

 

(1.0 %)

 

0.9 %

 

Adjusted EBITDA Margin

 

7.4 %

 

9.0 %

 

 

(dollars in thousands)

 

Trailing Twelve Months

 

Reconciliation of Net Income Attributable to Class A and B-1
   Common Stockholders to Adjusted EBITDA

 

July 29 ,
2023

   

January 28 ,
2023

   

July 30 ,
2022

 

Net income attributable to Class A and B-1 common stockholders

 

$

36,154

   

$

90,801

   

$

119,895

 

Add (deduct):

                 

Interest expense, net

   

132,068

     

100,611

     

78,932

 

Income tax expense

   

24,433

     

35,347

     

40,422

 

Depreciation and amortization

   

196,177

     

193,828

     

185,156

 

Income from equity method investees

   

(14,240)

     

(12,976)

     

(11,224)

 

Loss on partial extinguishment of debt

   

746

     

     

 

Asset impairments and write offs

   

1,658

     

1,992

     

9,597

 

Equity-based compensation

   

81,915

     

60,784

     

51,272

 

Other non-operating (income) loss

   

(1,892)

     

12,667

     

20,609

 

Mexico joint venture EBITDA (1)

   

33,583

     

29,584

     

28,254

 

Acquisition-related integration costs (2)

   

2,219

     

15,314

     

13,095

 

Other costs (3)

   

8,860

     

2,817

     

3,448

 

Adjusted EBITDA

 

$

501,681

   

$

530,769

   

$

539,456

 

Net sales

 

$

6,165,821

   

$

6,035,967

   

$

5,914,409

 

Net margin (4)

   

0.6

%

   

1.5

%

   

2.0

%

Adjusted EBITDA Margin

   

8.1

%

   

8.8

%

   

9.1

%

 

Adjusted Net Income and Adjusted EPS

Adjusted Net Income and Adjusted diluted Earnings Per Share attributable to Petco common stockholders (Adjusted EPS) are considered non-GAAP financial measures under the SEC's rules because they exclude certain amounts included in the net income attributable to Petco common stockholders and diluted earnings per share attributable to Petco common stockholders calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they facilitate comparison of the current period performance with that of the comparable prior period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers to be Petco's core earnings performance as well as the ability to make a more informed assessment of such earnings performance with that of the prior period.

(in thousands, except per share amounts)

 

13 Weeks Ended

 

Reconciliation of Diluted EPS to Adjusted EPS

 

July 29, 2023

   

July 30, 2022

 
   

Amount

   

Per share

   

Amount

   

Per share

 

Net (loss) income attributable to common stockholders / diluted EPS

 

$

(14,606)

   

$

(0.05)

   

$

13,456

   

$

0.05

 

Add (deduct):

                       

Income tax expense

   

6,732

     

0.02

     

6,638

     

0.02

 

Loss on partial extinguishment of debt

   

305

     

0.00

     

     

 

Asset impairments and write offs

   

1,031

     

0.01

     

1,207

     

0.01

 

Equity-based compensation

   

24,119

     

0.09

     

12,895

     

0.05

 

Other non-operating (income) loss

   

(1,795)

     

(0.01)

     

10,259

     

0.04

 

Acquisition-related integration costs (2)

   

     

     

10,859

     

0.04

 

Other costs (3)

   

6,183

     

0.02

     

3,427

     

0.01

 

Adjusted pre-tax income / diluted earnings per share

 

$

21,969

   

$

0.08

   

$

58,741

   

$

0.22

 

Income tax expense at 26% normalized tax rate

   

5,712

     

0.02

     

15,273

     

0.06

 

Adjusted Net Income / Adjusted EPS

 

$

16,257

   

$

0.06

   

$

43,468

   

$

0.16

 

 

Free Cash Flow

Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.

           

(in thousands)

 

13 Weeks Ended

 
   

July 29 ,
2023

 

July 30 ,
2022

 

Net cash provided by operating activities

 

$      96,614

 

$      42,569

 

Cash paid for fixed assets

 

(51,973)

 

(70,280)

 

Free Cash Flow

 

$      44,641

 

$     (27,711)

 

 

Non-GAAP Financial Measures Footnotes

(1)

Mexico Joint Venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.

   
   

13 Weeks Ended

 

(in thousands)

 

July 29 ,
2023

 

July 30 ,
2022

 

Net income

 

$        6,656

 

$        4,064

 

Depreciation

 

6,443

 

4,711

 

Income tax expense

 

2,364

 

2,390

 

Foreign currency loss

 

395

 

444

 

Interest expense, net

 

1,230

 

1,392

 

EBITDA

 

$      17,088

 

$      13,001

 

50% of EBITDA

 

$        8,544

 

$        6,501

 
   

(2)

Acquisition-related integration costs include direct costs resulting from acquiring and integrating businesses. These include third-party professional and legal fees and other integration-related costs that would not have otherwise been incurred as part of the company's operations.

(3)

Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.

(4)

We define net margin as net income attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-health--wellness-company-inc-reports-second-quarter-earnings-301908592.html

SOURCE Petco - Investor Relations

Investor Relations, Cathy Yao, cathy.yao@petco.com; Media Relations: Benjamin Thiele-Long, benjamin.thiele-long@petco.com

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order pet care coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.